Researchers analyzed data on 553 patients treated with imatinib, finding that complete cytogenetic response significantly impacted long-term outcome. Patients with low Philadelphia chromosome positivity had higher chances of achieving a complete response.
A new study found that three months is too soon to judge a patient's response to Gleevec, a common CML treatment. Researchers discovered that achieving a complete cytogenetic response had a significant impact on long-term outcome and survival rates.
A team from Stanford University is retracing the 1940s journey of John Steinbeck and Ed Ricketts to document changes in the Sea of Cortez. The expedition aims to raise awareness about the impact of tourism on the region, with a focus on conservation and sustainability.
Researchers discovered a two-fold increased risk of deep vein thrombosis and pulmonary embolism with estrogen plus progestin use. Age and obesity were primary determinants of increased absolute risk, while genetic variants such as Factor V Leiden also contributed to thrombosis risk.